Enrolling by invitationInterventionalPhase 2Last updated Aug 11, 2026

Alzheimer's Disease Research Center (ADRC) PET Component Study

Alzheimer's Disease Research Center PET Component

Overview

ClinicalTrials.gov ID: NCT07758660
Lead Sponsor: Patrick LaoOTHER
Brief Summary: The purpose of this study is to further engage and characterize Alzheimer's Disease Research Center (ADRC) participants through additional research opportunities, particularly PET imaging. Amyloid and Tau PET imaging will be collected in 24 participants per year, for a total of 120 participants over five years.

All participants will be followed longitudinally, including through potential transitions from normal aging to mild cognitive impairment (MCI) and Alzheimer's disease and related dementias (ADRD).

Status

Study Record Dates

NCT04437290Unknown status

University of Washington Alzheimer's Disease Research Center (UW ADRC) Imaging & Biomarker Core

NCT03706261Completed

Alzheimer's PET Imaging in Racially/Ethnically Diverse Adults

NCT02562989Completed

[18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001)

NCT04305210Unknown status

Alzheimer's Disease: Clinical Investigation and Neuroimage Studies Including 18F-PM-PBB3 and 18F-florbetapir (AV-45) PET Examination

NCT04104659Enrolling by invitation

Study of Tau Imaging With the Use of [18F]MK-6240 Tracer

NCT03287765Completed

Evaluating the Relationship Between Tau PET Imaging and CSF Biomarkers of AD (Alzheimer Disease) in Humans